BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2898288)

  • 1. Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene.
    Lee JS; Ro JS; Eisbruch A; Shtalrid M; Ferrell RE; Gutterman JU; Blick M
    Cancer Res; 1988 Jul; 48(14):4045-8. PubMed ID: 2898288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo methylation causes a tissue-specific polymorphic EcoRI pattern at the human epidermal growth factor receptor gene.
    del Arco A; Izquierdo M
    Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):591-5. PubMed ID: 8099283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction fragment length polymorphisms in the rat N-ras and retinoblastoma genes: their identification and characterization.
    Shepel LA; Gorski J
    Oncogene; 1990 Nov; 5(11):1675-82. PubMed ID: 1980008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the estrogen receptor gene structure in human breast cancer.
    Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
    Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A frequent restriction fragment length polymorphism in the human metallothionein-II processed gene region is evolutionarily conserved.
    Varshney U; Hoar DI; Starozik D; Gedamu L
    Mol Biol Med; 1984 Jun; 2(3):193-206. PubMed ID: 6100387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction fragment length polymorphism of the human insulin receptor gene among Mexican Americans.
    Raboudi SH; Frazier ML
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):319-35. PubMed ID: 2573118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taq I restriction polymorphism of HLA class-I genes, and hybridization with HLA-A and HLA-B specific probes.
    Huetz F; Mariotti M; Lucotte G
    Exp Clin Immunogenet; 1987; 4(1):1-7. PubMed ID: 2908510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of class I DNA Pvu II restriction HLA gene fragments with serologic alleles.
    Lucotte G; Coulondre C; Salmon C
    Exp Clin Immunogenet; 1985; 2(4):191-7. PubMed ID: 2908502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction fragment-length polymorphisms of class II gene sequences in mice expressing minor structural variants of I-Ak and I-Ap.
    McConnell TJ; Darby B; Wakeland EK
    J Immunol; 1986 Apr; 136(8):3076-84. PubMed ID: 3007611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of random cDNA clones as probes for human restriction fragment polymorphisms.
    Helentjaris T; Gesteland R
    J Mol Appl Genet; 1983; 2(3):237-47. PubMed ID: 6319525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of immunoglobulin lambda constant region genes in populations from France, Lebanon and Tunisia.
    Ghanem N; Dariavach P; Bensmana M; Chibani J; Lefranc G; Lefranc MP
    Exp Clin Immunogenet; 1988; 5(4):186-95. PubMed ID: 2908491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human restriction fragment length polymorphisms and cancer risk assessment.
    Krontiris TG; DiMartino NA; Colb M; Mitcheson HD; Parkinson DR
    J Cell Biochem; 1986; 30(4):319-29. PubMed ID: 3011817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphisms of the human N-myc gene: relationship to gene amplification.
    Kurosawa H; Yamada M; Nakagome Y
    Oncogene; 1987; 2(1):85-90. PubMed ID: 2894002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFalpha promoter polymorphisms.
    Fargion S; Valenti L; Dongiovanni P; Fracanzani AL
    Methods Mol Med; 2004; 98():47-58. PubMed ID: 15064432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12.
    Stenman G; Sahlin P; Mark J; Landys D
    Oncogene; 1991 Jul; 6(7):1105-8. PubMed ID: 1677749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms.
    Bahnak BR; Lavergne JM; Verweij CL; Rothschild C; Pannekoek H; Larrieu MJ; Meyer D
    Thromb Haemost; 1988 Oct; 60(2):178-81. PubMed ID: 2905841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of three biallelic restriction fragment length polymorphisms versus a polymorphic dinucleotide tandem repeat polymorphism at the low-density-lipoprotein receptor gene locus for diagnosis of familial hypercholesterolemia.
    Weiss N; Gudnasson V; Ostwald P; Humphries S; Schuster H; Keller C
    Dis Markers; 1997 Nov; 13(3):141-51. PubMed ID: 9405927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
    Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
    Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
    Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.
    Sasaki M; Karube A; Karube Y; Watari M; Sakuragi N; Fujimoto S; Dahiya R
    Biochem Biophys Res Commun; 2005 Apr; 329(1):100-4. PubMed ID: 15721279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.